About this episode
In the final episode of our four-part series “Hot Topics in Neonatology” we explore neonatal abstinence syndrome (NAS), a byproduct of prenatal drug exposure — one of the fastest growing public health problems in the world. In the U.S., the most recent data from the CDC indicate that the number of pregnant people with opioid-related diagnoses documented at delivery increased by 131% from 2010 to 2017. The implications for their babies include preterm birth, still birth, birth defects and neonatal abstinence syndrome, or NAS. SEGMENT 1: We talk with Dr. Ju-Lee Oei from the Royal Hospital for Women in Sydney, Australia, who provides an overview NAS — what it is, how it's diagnosed and how it's treated. SEGMENT 2: Andre Sukta, a research and development projects manager at the United States Drug Testing Laboratories in Chicago, joins us to talk about the recent history of newborn toxicology screening. Carol Vassar, producer/host Explore the Full Series : Part 1, Episode 50 The NICU View: Mom & Baby Part 2, Episode 51 Fluid Dynamics: What's New in Treating EPRA Part 3, Episode 52 Fragile Beginnings: Exploring NEC in Newborns Views expressed by guests do not necessarily reflect the views of the host or management. Subscribe, review or let your voice be heard at NemoursWellBeyond.org .